Elite Diagnostic Limited (JMSE:ELITE)

Market Cap	554.84M -15.1%
Revenue (ttm)	867.29M +1.6%
Net Income	27.60M -13.8%
EPS	0.08 -13.8%
Shares Out	353.40M
PE Ratio	20.10
Forward PE	n/a
Dividend	0.01 (0.64%)
Ex-Dividend Date	Sep 19, 2025

Volume	331,526
Open	n/a
Previous Close	1.620
Day's Range	1.570 - 1.650
52-Week Range	1.020 - 2.000
Beta	0.09
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Elite Diagnostic

Elite Diagnostic Limited engages in the provision of diagnostic imaging services in Jamaica. It offers medical imaging services, including CT scan, MRI, X-Ray, ultrasound, and fluoroscopy services. The company also provides interventional procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In fiscal year 2026, Elite Diagnostic's revenue was 867.29 million, an increase of 1.58% compared to the previous year's 853.82 million. Earnings were 27.60 million, a decrease of -13.82%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error